Delivery Order SPE2DB22D3009-SPE2DB25FAH50
Award Date
10/30/24
Potential Completion Date
10/31/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,575.18, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 4, 2024. The contract has a completion date of November 5, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,511.04 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024 with a completion date of October 29, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,344.65, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
The federal contract award is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $1,369.35, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a term running through January 23, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $3,226.34 and is a firm fixed-price delivery order contract with a completion date of November 6, 2023. AmerisourceBergen holds a larger Indefinite Delivery...
The federal contract award is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products. The contract, valued at $1,428.02, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price and has an ultimate completion date of June 18, 2025. AmerisourceBergen Drug Corp is a significant vendor for the DLA, holding...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the drug product XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The $1,779.48 firm fixed-price delivery order was awarded on October 22, 2024 by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of October 23, 2024. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,525.11, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,024.09, is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, to support military healthcare programs. This is a Firm Fixed Price Delivery Order contract with a completion date of November 12, 2024. The contract is not designated as a set-aside....
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML. The contract has a ceiling value of $2,719.51 and runs through October 23, 2024. This delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC enables the...